Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Biolexis Therapeutics has achieved a transformative milestone in metabolic drug discovery with the successful resolution of ...

"Billionaire" and "successful hedge fund manager" are titles that carry significant weight on Wall Street. These and others ...

Mehmet Oz will likely face questions during his confirmation hearing about his past support of expanding the Medicare ...

This notice has been issued due to an electrical issue after severe thunderstorms, the Texas Commission on Environmental ...

In December 2024, ProQR expanded its collaboration with the Rett Syndrome Research Trust, securing additional funding for a total of up to $9.2 million to support the advancement of AX-2402, an RNA ...

A new high-profile event dedicated to global TV series is being launched in Italy with “Bridgerton” star Adjoa Andoh, ...

The global market for acute migraine treatment is on a steady growth trajectory, with sales expected to rise from USD 2,700.7 million in 2024 to USD 4,194.1 million by 2034, reflecting a CAGR of 4.5% ...

Senators ask if contracts between drugmakers and telehealth companies violate the federal anti-kickback statute.

U.S. drugmakers Johnson & Johnson and Eli Lilly increased spending on security for their top executives in 2024, citing ...

Roche and Zealand Pharma inked a $5.3 billion deal Wednesday to collaborate on a weight-loss drug in the amylin class.

Eli Lilly revealed major advancements in its alopecia and atopic dermatitis studies, likely driving its 3.77% stock rise. The ...